AbstractWe obtained sealed vials of two different polio vaccine lots, expiration date 1955, which were used in the first U.S. polio vaccine campaign. These early lots were pulled from the market because they contained live infectious poliovirus which caused polio in some of the vaccines. Theoretically, these vaccines could have contained other infectious retroviruses, including HIV. No viral sequences were detected using RT-PCR analyses with primers capable of amplifying chimpanzee SIV and HIV-1-related viruses nor with primers for macaque SIV, sooty mangabey SIV, and HIV-2-related viruses. Poliovirus sequences were readily amplified by RT-PCR, suggesting that the technique used would have detected SIV or HIV sequences, if present
In order to evaluate the role of persisting virus replication during occult phase immunisation in th...
AbstractIn the search for an effective vaccine against the human immunodeficiency virus (HIV), novel...
AbstractThe use of HIV-1env/SIVmacchimeric viruses expressing divergent HIV-1 envelopes of clinical ...
AbstractWe obtained sealed vials of two different polio vaccine lots, expiration date 1955, which we...
A book published in 1999 hypothesized that the scientists who worked with the CHAT type 1 attenuated...
While oral polio vaccine (OPV) has been shown to be safe and effective, it has been observed that it...
Abstract Background Poliomyelitis is an acute viral infection caused by poliovirus and transmitted v...
Objective: To estimate the rate of long-term poliovirus excretors in people known to have B-cell imm...
AbstractStudies in non-human primates, with simian immunodeficiency virus (SIV) and simian/human imm...
AbstractBackgroundDefinitive identification of poliovirus strains in vaccines is essential for quali...
Background: Humans are the only host of polioviruses, thus the prospects of global polio eradication...
Background. With prolonged replication, attenuated polioviruses used in oral polio vaccine (OPV) can...
AbstractHuman immunodeficiency virus (HIV) is the cause of one of the most lethal pandemics in human...
AbstractTransient SIV viremia after experimental SIV challenge has been documented. Whether SIV pers...
Background: Live attenuated simian immunodeficiency virus (SIV) vaccines represent the most effectiv...
In order to evaluate the role of persisting virus replication during occult phase immunisation in th...
AbstractIn the search for an effective vaccine against the human immunodeficiency virus (HIV), novel...
AbstractThe use of HIV-1env/SIVmacchimeric viruses expressing divergent HIV-1 envelopes of clinical ...
AbstractWe obtained sealed vials of two different polio vaccine lots, expiration date 1955, which we...
A book published in 1999 hypothesized that the scientists who worked with the CHAT type 1 attenuated...
While oral polio vaccine (OPV) has been shown to be safe and effective, it has been observed that it...
Abstract Background Poliomyelitis is an acute viral infection caused by poliovirus and transmitted v...
Objective: To estimate the rate of long-term poliovirus excretors in people known to have B-cell imm...
AbstractStudies in non-human primates, with simian immunodeficiency virus (SIV) and simian/human imm...
AbstractBackgroundDefinitive identification of poliovirus strains in vaccines is essential for quali...
Background: Humans are the only host of polioviruses, thus the prospects of global polio eradication...
Background. With prolonged replication, attenuated polioviruses used in oral polio vaccine (OPV) can...
AbstractHuman immunodeficiency virus (HIV) is the cause of one of the most lethal pandemics in human...
AbstractTransient SIV viremia after experimental SIV challenge has been documented. Whether SIV pers...
Background: Live attenuated simian immunodeficiency virus (SIV) vaccines represent the most effectiv...
In order to evaluate the role of persisting virus replication during occult phase immunisation in th...
AbstractIn the search for an effective vaccine against the human immunodeficiency virus (HIV), novel...
AbstractThe use of HIV-1env/SIVmacchimeric viruses expressing divergent HIV-1 envelopes of clinical ...